Fujita H, Sueyoshi S, Tanaka T, Toh U, Mine T, Sasahara H, Shirouzu K, Yamana H, Toda Y, Hayabuchi N
Dept. of Surgery, Kurume University School of Medicine, Fukuoka, Japan.
Gan To Kagaku Ryoho. 2000 Nov;27(13):2016-22.
In responders to neoadjuvant chemoradiotherapy for locally-advanced esophageal cancer, there was no significant difference in the long-term outcome between patients who underwent esophagectomy and those who did not. Esophagectomy might be unnecessary for patients who achieve a complete response with chemoradiotherapy for an esophageal cancer, in cases when salvage surgery is considered in order to treat any future recurrence.
在接受新辅助放化疗的局部晚期食管癌患者中，接受食管切除术的患者与未接受食管切除术的患者的长期预后无显著差异。对于经放化疗后达到完全缓解的食管癌患者，在考虑进行挽救性手术以治疗未来任何复发情况时，食管切除术可能并无必要。
